C86.2 Enteropathy-type (intestinal) T-cell lymphoma

Name of the Condition

• Enteropathy-type (intestinal) T-cell lymphoma
• ICD-10 Code: C86.2

Summary

Enteropathy-type (intestinal) T-cell lymphoma is a rare, aggressive non-Hodgkin lymphoma that originates from T-cells in the gastrointestinal tract, most commonly the small intestine. It is strongly associated with celiac disease and may present with intestinal perforation, bleeding, or obstruction. The disease can progress rapidly and may involve other organs if left untreated.

Causes

The exact cause involves genetic mutations in intestinal T-cells leading to uncontrolled proliferation. Chronic immune stimulation from celiac disease (especially in untreated or refractory cases) is a key contributing factor. Environmental exposures and immune dysregulation may also play a role in its development.

Risk Factors

• Untreated or refractory celiac disease
• Long-term gluten exposure in genetically predisposed individuals
• Immunosuppression (e.g., from medications or HIV)
• Prior gastrointestinal surgeries or conditions
• Male gender
• Advanced age (most commonly reported in older adults)

Symptoms

• Abdominal pain or cramping
• Unexplained weight loss
• Chronic diarrhea or malabsorption
• Intestinal bleeding or perforation
• Fatigue or weakness
• Nausea or vomiting
• Fever or night sweats

Diagnosis

Diagnosis involves a physical examination, followed by endoscopic biopsy of the intestinal mucosa to confirm lymphoma type. Imaging (CT, PET) assesses disease extent, and blood tests evaluate cell counts, nutritional status, and organ function. Histopathology and immunophenotyping are critical for differentiation from other gastrointestinal malignancies.

Treatment Options

Treatment typically includes systemic chemotherapy (e.g., CHOP or more intensive regimens) and may involve surgical intervention for complications like perforation. Nutritional support and management of celiac disease (if present) are essential. Stem cell transplantation may be considered in select cases.

Prognosis and Follow-Up

Prognosis is generally poor due to the aggressive nature of the disease, though early diagnosis and treatment can improve outcomes. Follow-up includes regular imaging, endoscopic evaluations, and monitoring for recurrence or complications. Long-term surveillance for celiac disease management is also recommended.

Complications

• Intestinal perforation or bleeding
• Malnutrition or vitamin deficiencies
• Sepsis from gastrointestinal infections
• Spread to other organs (e.g., liver, lymph nodes)
• Treatment-related toxicities (e.g., chemotherapy side effects)

Lifestyle & Prevention

• Strict adherence to a gluten-free diet (if celiac disease is present)
• Regular medical monitoring for celiac disease complications
• Prompt treatment of gastrointestinal symptoms
• Avoidance of known environmental triggers (if identified)
• Nutritional support to maintain weight and strength

When to Seek Professional Help

Seek immediate medical attention for severe abdominal pain, vomiting, fever, or signs of intestinal bleeding (e.g., black stools, dizziness). Persistent diarrhea, unexplained weight loss, or fatigue lasting more than a few weeks should also prompt evaluation.

Tips for Medical Coders

Document the association with celiac disease (if present) and specify the intestinal site of involvement. Include details on biopsy results, imaging findings, and treatment plans to support code assignment. Ensure differentiation from other gastrointestinal lymphomas or celiac disease complications.